Why the study?
There were limited data on how glycemia and insulin resistance markers associate with arterial stiffness.
Are higher levels of glycemia and insulin resistance markers associated with abnormal arterial stiffness in community-dwelling individuals?
Observational (n=6,617)
Are higher levels of glycemia and insulin resistance markers associated with abnormal arterial stiffness in community-dwelling individuals?
Worse glycemia and insulin sensitivity are associated with abnormal arterial stiffness in community-dwelling individuals, highlighting a potential mechanism for increased cardiovascular risk.
Answers are grounded in this paper and cite their sources.
Associations with arterial stiffness should not change practice; this extends limited observational data but leaves causality open.
BACKGROUND: There is limited data on the associations of (glycated hemoglobin A1C [HbA 1C ], fasting plasma glucose, and 2-hour postload glucose) and insulin resistance (fasting plasma insulin, insulin-to-glucose ratio, homeostasis model assessment of insulin resistance, and quantitative insulin sensitivity check index) markers with arterial stiffness. METHODS: We included 6617 Framingham Heart Study participants (53.8% women; 6.9% diabetes, mean age: 48±14 years). Arterial stiffness measures included natural log (Ln)-transformed carotid-femoral pulse wave velocity, augmentation index (AIx), central pulse pressure, carotid-brachial pulse wave velocity, carotid-radial pulse wave velocity, and brachial pulse pressure. Estimates of associations were adjusted for several clinical characteristics. RESULTS: Adjusted means of log (Ln)-transformed carotid-femoral pulse wave velocity, AIx, and carotid-brachial pulse wave velocity were increasingly abnormal with higher HbA 1C (all P <0.05). Each 1% higher HbA 1C was associated with elevated CFPWV (odds ratio [OR], 1.24 [95% CI, 1.11–1.39]) and lower AIx (OR, 0.86 [95% CI, 0.78–0.95]). Each 10-mg/dL higher fasting plasma glucose was associated with elevated CFPWV (OR, 1.09 [95% CI, 1.05–1.13]), but lower AIx (OR, 0.91 [95% CI, 0.87–0.94]). Each 10-mg/dL higher 2-hour postload glucose was associated with elevated CFPWV (OR, 1.04 [95% CI, 1.01–1.07]), central pulse pressure (OR, 1.04 [95% CI, 1.02–1.06]), brachial pulse pressure (OR, 1.04 [95% CI, 1.02–1.06]), but lower AIx (OR, 0.94 [95% CI, 0.91–0.96]). Higher fasting plasma insulin, insulin-to-glucose ratio, homeostasis model assessment of insulin resistance, and lower quantitative insulin sensitivity check index were associated with higher CFPWV and lower AIx (all P <0.05). CONCLUSIONS: In community-dwelling individuals, worse glycemia and insulin sensitivity were associated with abnormal arterial stiffness.
No takes yet. Share an insight, caveat, or question.
Noumegni et al. (2026) conducted an observational in Community-dwelling individuals (n=6,617). Higher glycemia and insulin sensitivity markers (e.g., HbA1c, fasting plasma glucose) vs. Lower levels of glycemia and insulin sensitivity markers was evaluated on Elevated carotid-femoral pulse wave velocity (CFPWV) per 1% higher HbA1c (OR 1.24, 95% CI 1.11-1.39, p=<0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: